Establishment of three cisplatin-resistant endometrial cancer cell lines using two methods of cisplatin exposure

Author： Sagawa Yasukazu  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.32, Iss.2, 2011-04, pp. : 399-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis

By Orlandi L.   Colella G.   Bearzatto A.   Abolafio G.   Manzotti C.   Daidone M.G.   Zaffaroni N.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 649-659

Elsevier

Access to resources Recommend Favorite

Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle

By                            

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 923-933

Spandidos Publications

Access to resources Recommend Favorite

The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway

By                      

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 619-624

Spandidos Publications

Access to resources Recommend Favorite

Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

By Luo Hong  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 937-945

Springer Publishing Company

Access to resources Recommend Favorite

Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells

By        

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 425-430

Spandidos Publications

Access to resources Recommend Favorite